Azienda Unita Sanitaria Locale di Ravenna

Ravenna 48121

0 studies enrolling now · 6 studies all time

What they study most

Advanced Malignancies, Carcinoma, Chronic Lymphocytic Leukemia, Endometrial Neoplasms, Immune Thrombocytopenic Purpura (ITP), Lung Cancer, Mature B-Cell Malignancies, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Small Lymphocytic Lymphoma

Studies at this site

• Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies — Running, not enrolling
• A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL — Running, not enrolling
• Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients — Stopped early
• A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer — Completed
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants — Completed
• Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET — Completed